- Report
- December 2023
- 250 Pages
Global
€4485EUR$4,995USD£3,819GBP
- Report
- May 2023
- 88 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Report
- October 2023
- 102 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Report
- July 2024
- 132 Pages
Global
From €853EUR$950USD£726GBP
The Preclinical CRO market is a subset of the Drug Discovery industry, focusing on the preclinical stages of drug development. Preclinical CROs provide services such as drug safety testing, pharmacology studies, and toxicology studies. These services are used to assess the safety and efficacy of potential drugs before they are tested in humans. Preclinical CROs also provide services such as drug metabolism and pharmacokinetics, which are used to understand how a drug is absorbed, distributed, metabolized, and eliminated in the body.
Preclinical CROs are an important part of the drug discovery process, as they provide the data needed to move a drug candidate forward in the development process. Preclinical CROs are also used to reduce the cost and time associated with drug development, as they can provide the data needed to make decisions quickly and efficiently.
Some companies in the Preclinical CRO market include Charles River Laboratories, WuXi AppTec, Covance, PRA Health Sciences, and Envigo. Show Less Read more